Sign Up to like & get
recommendations!
0
Published in 2018 at "International Journal of Cancer"
DOI: 10.1002/ijc.31292
Abstract: Pancreatic ductal adenocarcinoma (PDAC) is one of the most lethal malignancies. BRCA‐associated PDAC comprises a clinically relevant subtype. A portion of these patients are highly susceptible to DNA damaging therapeutics, however, responses are heterogeneous and…
read more here.
Keywords:
brca associated;
hrd genome;
treatment;
Sign Up to like & get
recommendations!
0
Published in 2024 at "Cancer Research"
DOI: 10.1158/1538-7445.sabcs23-po5-21-07
Abstract: Rationale. BRCA-associated triple-negative breast cancer (TNBC) is one of the most aggressive subtypes of breast cancer with high sensitivity to chemotherapy, which leads to increased interest in the development of new strategies for neoadjuvant treatment…
read more here.
Keywords:
breast cancer;
brca associated;
triple negative;
group ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2020 at "BMC Cancer"
DOI: 10.1186/s12885-020-07481-1
Abstract: Background The BRCA mutation (BRCAm) in males has been reported to confer a higher risk for the development of various tumors. However, little is known about its clinicopathologic features and prognostic implications. Design We conducted…
read more here.
Keywords:
tumor survey;
associated tumors;
pan tumor;
prognostic implications ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2017 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2017.35.15_suppl.1539
Abstract: 1539Background: Hispanic women with BC present at a younger age, have a higher frequency of BRCA mutations and show a worse incidence-to-mortality ratio than non-Hispanic women. Information regarding the characteristics of BRCA-associated BC in Hispanics…
read more here.
Keywords:
hispanic patients;
genetic clinical;
characteristics brca;
cancer ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2017 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2017.35.4_suppl.332
Abstract: 332Background: Pancreatic ductal adenocarcinoma (PDAC) associated with germline BRCA1 or BRCA2mutations may have selective sensitivity to agents that exploit homologous recombination DNA repair defects. We hypothesized that cisplatin, a DNA-crosslinking agent, and talazoparib, a poly(ADP-ribose)…
read more here.
Keywords:
trial;
trial evaluate;
cisplatin;
brca associated ... See more keywords